EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 231 filers reported holding EDITAS MEDICINE INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $522,139 | -9.1% | 66,946 | -4.0% | 0.00% | 0.0% |
| Q2 2023 | $574,139 | +89.2% | 69,758 | +66.6% | 0.00% | 0.0% |
| Q1 2023 | $303,506 | -22.6% | 41,881 | -5.0% | 0.00% | 0.0% |
| Q4 2022 | $391,879 | -36.0% | 44,093 | -11.6% | 0.00% | 0.0% |
| Q3 2022 | $612,000 | -2.9% | 49,872 | -6.4% | 0.00% | 0.0% |
| Q2 2022 | $630,000 | -36.0% | 53,290 | +3.2% | 0.00% | -50.0% |
| Q1 2022 | $985,000 | -33.7% | 51,620 | -7.6% | 0.00% | -33.3% |
| Q4 2021 | $1,485,000 | -32.6% | 55,885 | +4.2% | 0.00% | -40.0% |
| Q3 2021 | $2,203,000 | -45.2% | 53,609 | -24.5% | 0.01% | -44.4% |
| Q2 2021 | $4,022,000 | +66.8% | 71,028 | +24.6% | 0.01% | +50.0% |
| Q1 2021 | $2,411,000 | +12.9% | 56,987 | +87.0% | 0.01% | 0.0% |
| Q4 2020 | $2,136,000 | +232.2% | 30,470 | +33.4% | 0.01% | +200.0% |
| Q3 2020 | $643,000 | -16.4% | 22,844 | -12.1% | 0.00% | -33.3% |
| Q2 2020 | $769,000 | +84.0% | 25,987 | +24.3% | 0.00% | +50.0% |
| Q1 2020 | $418,000 | – | 20,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |